Risk of second cancers after the diagnosis of Merkel cell carcinoma in Scandinavia
2011

Risk of Second Cancers After Merkel Cell Carcinoma

Sample size: 756 publication Evidence: high

Author Information

Author(s): Bzhalava D, Bray F, Storm H, Dillner J

Primary Institution: Malmö University Hospital, Lund University

Hypothesis

Does the diagnosis of Merkel cell carcinoma (MCC) increase the risk of developing second primary cancers?

Conclusion

Patients diagnosed with MCC are at increased risk of a second cancer, particularly other skin cancers.

Supporting Evidence

  • The overall cancer incidence was increased among patients diagnosed with MCC compared to the general population.
  • Significantly increased incidence ratios were found for non-melanoma skin cancers, melanoma of skin, and laryngeal cancer.
  • The study cohort included all persons registered with MCC from 1980 to 2007 in Denmark and from 1990 to 2007 in Norway and Sweden.

Takeaway

If someone has Merkel cell carcinoma, they might get other types of cancer later, especially skin cancers.

Methodology

The study used national cancer registries in Denmark, Norway, and Sweden to analyze the risk of second cancers after MCC diagnosis.

Potential Biases

Surveillance bias may affect the observed risk of secondary cancers due to increased medical attention after MCC diagnosis.

Limitations

The study may have limited follow-up time and a small number of patients with other cancers occurring before or at the same time as MCC.

Participant Demographics

The cohort included 756 individuals diagnosed with MCC, with a mean age of 75 years, and a female to male ratio of 1.4:1.

Statistical Information

Confidence Interval

95% CI: 1.10–1.72

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6605989

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication